Salgado Fernández, Mercedes
Reboredo López, Margarita
Covela Rúa, Marta
Candamio, Sonia
González-Villarroel, Paula
Sánchez-Cousido, Luis Felipe
Graña, Begoña
Carral-Maseda, Alberto
Cameselle-García, Soledad
Varela Pose, Vanesa
Gallardo-Martín, Maria Elena
Martínez-Lago, Nieves
,
Funding for this research was provided by:
Merck S.L.U.
Article History
Accepted: 5 April 2024
First Online: 23 May 2024
Declarations
:
: Medical writing and editorial support were provided by Pilar López, PhD, of LIDESEC, and funded by Merck S.L.U., Spain, an affiliate of Merck KGaA, Darmstadt, Germany.
: <i>M</i><i>SF:</i> Advisory board—Pfizer, GlaxoSmithKline, and Amgen; speaker—Amgen, Sanofi, Rovi, Leo Pharma, Techdow, Eisai, MSD, AstraZeneca, Roche, Merck Serono, Servier, and Lilly; financing meetings and travel/accommodation—Servier and Merck Serono. <i>ACM:</i> Advisory board and/or financing meetings and travel/accommodation—Bayer, Servier, Merck, and Amgen. <i>PGV:</i> financing meetings and travel/accommodation—Amgen. <i>MEGM:</i> financing meetings and travel/accommodation—Amgen. <i>BGS:</i> Advisory board and/or financing meetings and travel/accommodation—Amgen, AstraZeneca, Bristol Myers Squibb, Celgene, Gilead Sciences, Merck, Sanofi, and Servier. <i>NML:</i> Consultant or advisory role—AAA (Novartis), Amgen, Bayer, BMS, Esteve, Ipsen, Leo Pharma, Lilly, Merck, MSD, Pierre Fabre, and Servier; travel grant—Amgen, Advanz, Ipsen, Lilly, and Servier. <i>MRL</i>, <i>MCR</i>, <i>SCF</i>, <i>LFSC</i>, <i>SCG,</i> and <i>VVP</i> report they have nothing to disclose.
: The study protocol was approved on 31 March 2022 by the Galician Ethics Committee of Research with Medicines (CEIm-G), prior to starting data collection. This observational study was performed in accordance with ethical principles that are consistent with the Declaration of Helsinki, the International Conference on Harmonisation’s Guidelines for Good Clinical Practice, the Guidelines for Good Pharmacoepidemiology Practices, and applicable legislation on noninterventional studies and/or observational studies.
: Written informed consent was obtained from all living individual participants. Deceased patients were included in the study, except those who expressed their objection to the use of their data for research or to participation in research studies.
: All authors contributed to the study conception and design, material preparation, and data collection and analysis. All authors commented on previous versions of the manuscript and contributed to the writing of the manuscript. All authors read and approved the final manuscript.
: The data that support the findings of this study are not openly available; they are available from the corresponding author upon reasonable request.